A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma

Abstract excerpt

BACKGROUND: Subtypes are widely found in cancer. They are characterized with different behaviors in clinical and molecular profiles, such as survival rates, gene signature and copy number aberrations (CNAs). While cancer is generally believed to have been caused by genetic aberrations, the number of such events is tremendous in the cancer tissue and only a small subset of them may be tumorigenic. On the other...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gene expression and cancer classification
• Share to Genomic variations and chromosomal abnormalities
• Share to Glioma Diagnosis and Treatment